Prioritization and barriers of mpox vaccination uptake among gay, bisexual and other men who have sex with men in Taiwan: 2023 HEART survey

IF 4.5 3区医学 Q2 IMMUNOLOGY

Vaccine Pub Date : 2025-04-01 DOI:10.1016/j.vaccine.2025.127059

Carol Strong , Patricia Joson , Isaac Yen-Hao Chu , Tsan-Tse Chuang , Huei-Jiuan Wu , Chia-Wen Li , PoYao Huang , Adam Bourne , Stephane Wen-Wei Ku

{"title":"Prioritization and barriers of mpox vaccination uptake among gay, bisexual and other men who have sex with men in Taiwan: 2023 HEART survey","authors":"Carol Strong , Patricia Joson , Isaac Yen-Hao Chu , Tsan-Tse Chuang , Huei-Jiuan Wu , Chia-Wen Li , PoYao Huang , Adam Bourne , Stephane Wen-Wei Ku","doi":"10.1016/j.vaccine.2025.127059","DOIUrl":null,"url":null,"abstract":"<div><div>During Taiwan's early 2023 mpox outbreak, limited vaccine availability required targeting mpox vaccine priority groups (MVPs) for effective control, including individuals with multiple sexual partners, sex workers, and those with a history of sexually transmitted infections (STIs). This study examines whether Taiwan's prioritization efforts reached MVPs. In November–December 2023, we surveyed 1656 gay, bisexual or other men who have sex with men (GBMSM) in Taiwan via social media. Of respondents, 43 % were unvaccinated, 13 % had received one dose, and 44 % completed double doses. Receiving two doses was associated with living with HIV, having multiple sexual partners, and condomless anal sex (CAS) in the last three months. Receiving two doses were also associated with other preventive behaviors, including being on pre-exposure prophylaxis (PrEP) and receiving human papillomavirus (HPV) vaccine. Despite Taiwan's free mpox vaccines efforts, uptake and completion challenges remain, highlighting the need for increased awareness and access among susceptible populations.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"53 ","pages":"Article 127059"},"PeriodicalIF":4.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25003561","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

During Taiwan's early 2023 mpox outbreak, limited vaccine availability required targeting mpox vaccine priority groups (MVPs) for effective control, including individuals with multiple sexual partners, sex workers, and those with a history of sexually transmitted infections (STIs). This study examines whether Taiwan's prioritization efforts reached MVPs. In November–December 2023, we surveyed 1656 gay, bisexual or other men who have sex with men (GBMSM) in Taiwan via social media. Of respondents, 43 % were unvaccinated, 13 % had received one dose, and 44 % completed double doses. Receiving two doses was associated with living with HIV, having multiple sexual partners, and condomless anal sex (CAS) in the last three months. Receiving two doses were also associated with other preventive behaviors, including being on pre-exposure prophylaxis (PrEP) and receiving human papillomavirus (HPV) vaccine. Despite Taiwan's free mpox vaccines efforts, uptake and completion challenges remain, highlighting the need for increased awareness and access among susceptible populations.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Vaccine 医学-免疫学

CiteScore

8.70

自引率

5.50%

发文量

992

审稿时长

131 days

期刊介绍： Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.